At the time of writing, Apyx Medical Corp [APYX] stock is trading at $1.58, up 42.99%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The APYX shares have gain 47.66% over the last week, with a monthly amount glided 64.93%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stephens started tracking the stock with Overweight rating on July 14, 2023, and set its price target to $8. On May 20, 2022, Lake Street initiated with a Buy rating and assigned a price target of $12 on the stock. Dougherty & Company reiterated its Buy rating and decreased its price target to $9 on April 02, 2019.
For the past year, the stock price of Apyx Medical Corp fluctuated between $0.76 and $1.95. Currently, Wall Street analysts expect the stock to reach $8.5 within the next 12 months. Apyx Medical Corp [NASDAQ: APYX] shares were valued at $1.58 at the most recent close of the market. An investor can expect a potential return of 437.97% based on the average APYX price forecast.
Analyzing the APYX fundamentals
According to Apyx Medical Corp [NASDAQ:APYX], the company’s sales were 47.29M for trailing twelve months, which represents an -7.95% plunge. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.32%, Pretax Profit Margin comes in at -0.42%, and Net Profit Margin reading is -0.42%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -1.59 and Total Capital is -0.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2267 points at the first support level, and at 0.8733 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8467, and for the 2nd resistance point, it is at 2.1133.
Ratios To Look Out For
It is important to note that Apyx Medical Corp [NASDAQ:APYX] has a current ratio of 5.45. As well, the Quick Ratio is 4.64, while the Cash Ratio is 3.26. Considering the valuation of this stock, the price to sales ratio is 1.26, the price to book ratio is 5.68.
Transactions by insiders
Recent insider trading involved HILL MATTHEW C, Chief Financial Officer, that happened on Aug 13 ’24 when 5336.0 shares were purchased.
